{
    "clinical_study": {
        "@rank": "134520", 
        "acronym": "CAST", 
        "arm_group": [
            {
                "arm_group_label": "Physical Health Training", 
                "arm_group_type": "No Intervention", 
                "description": "The Physical Health Training condition will include information on the importance and benefits of a healthy lifestyle. Additionally, the program will discuss guidelines for a healthy lifestyle including information on diet, water consumption, exercise, and sleep."
            }, 
            {
                "arm_group_label": "Anxiety Risk Reduction", 
                "arm_group_type": "Experimental", 
                "description": "The anxiety risk reduction intervention will include psychoeducation focused on the nature of stress and its effect on the body. Interoceptive exposure exercises that were designed to correct the conditioned fear of bodily sensations will be explained and practiced."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to test the effectiveness and usability of a computer-based\n      treatment for mood and anxiety relevant risk factors. The target of the treatment is related\n      to cognitive stress, which has been shown to be associated with several negative mental\n      health outcomes such as suicidal ideation, substance use disorders, and Post-Traumatic\n      Stress Disorder."
        }, 
        "brief_title": "Cognitive Anxiety Sensitivity Treatment for Suicide", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Anxiety", 
        "condition_browse": {
            "mesh_term": [
                "Anxiety Disorders", 
                "Suicide"
            ]
        }, 
        "detailed_description": {
            "textblock": "CAST is a newly developed computerized treatment targeting specific risk factors associated\n      with PTSD, substance use, anxiety, and suicide. Eligible individuals will be randomized to\n      one of two conditions. In both conditions, participants will complete various self-report\n      questionnaires and a computerized presentation. Additionally, all participants will be asked\n      to complete a one month follow-up appointment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At or above the community sample mean on the ASI\n\n          -  English speakers\n\n          -  18 years of age or older\n\n        Exclusion Criteria:\n\n          -  Significant medical illness\n\n          -  Current substance dependence\n\n          -  Current or past psychotic-spectrum disorders\n\n          -  Uncontrolled bipolar disorder\n\n          -  Serious suicidal intent that warranted immediate medical treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "108", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01947179", 
            "org_study_id": "03969"
        }, 
        "intervention": {
            "arm_group_label": "Anxiety Risk Reduction", 
            "description": "Involves psychoeducation and interoceptive exposure exercises", 
            "intervention_name": "Anxiety Risk Reduction", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tallahassee", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32304"
                }, 
                "name": "Florida State University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Development and Evaluation of a Brief, Suicide Prevention Intervention Reducing Anxiety Sensitivity", 
        "other_outcome": {
            "description": "The PDS is a self-report measure used to assess the severity of posttraumatic stress symptoms during the past month.  The measure was designed based on Diagnostic and Statistical Manual-IV criteria. Respondents report if they have experienced any of 12 traumatic events, including an \"other\" category, and then indicate which event was the most disturbing. Additionally, respondents rate the frequency of 17 PTSD symptoms experienced in the past month in relation to the most disturbing event they endorsed. The PDS has excellent psychometric properties and can be used as a continuous measure of PTSD symptom severity.", 
            "measure": "Posttraumatic Diagnostic Scale (PDS)", 
            "safety_issue": "No", 
            "time_frame": "Month one follow-up"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The ASI is a 16-item self-report measure of anxiety sensitivity. Each item consists of a possible negative consequence of anxiety symptoms. The scale assesses three AS subfactors including cognitive, physical, and social concerns. The measure has shown good psychometric properties.", 
            "measure": "Anxiety Sensitivity Index (ASI)", 
            "safety_issue": "No", 
            "time_frame": "Month one follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01947179"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Florida State University", 
            "investigator_full_name": "Norman Schmidt", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The BSS is a 21-item widely used self-report measure assessing a broad spectrum of behaviors and attitudes related to suicide risk, including suicidal ideation and past suicide attempts. It has demonstrated strong reliability and validity.", 
            "measure": "Beck Suicide Scale (BSS)", 
            "safety_issue": "Yes", 
            "time_frame": "Month one follow-up"
        }, 
        "source": "Florida State University", 
        "sponsors": {
            "collaborator": {
                "agency": "Department of Defense", 
                "agency_class": "U.S. Fed"
            }, 
            "lead_sponsor": {
                "agency": "Florida State University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}